重复部分肾切除术：手术、功能和肿瘤学结果。
Repeat partial nephrectomy: surgical, functional and oncological outcomes.
机构信息
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Curr Opin Urol. 2011 Sep;21(5):368-75. doi: 10.1097/MOU.0b013e32834964ea.
Abstract
PURPOSE OF REVIEW
The greater utilization of partial nephrectomy and ablative procedures has increased the incidence of patients presenting with local renal recurrence. The choice to either perform a partial or radical nephrectomy in these situations can be a challenging decision.
RECENT FINDINGS
Repeat and salvage partial nephrectomy, while challenging and potentially associated with increased complications, offers patients the ability to maintain excellent renal functional outcomes and promising oncologic outcomes at intermediate follow-up.
SUMMARY
Surgeons should be familiar with the surgical complications and the functional and oncologic outcomes of reoperative nephron-sparing surgery (NSS). Recent data and outcome analysis support utilization of these procedures in patients presenting with either local recurrence or de-novo lesions in the ipsilateral kidney.
摘要
目的综述
部分肾切除术和消融术的广泛应用增加了局部肾复发患者的数量。在这些情况下，选择进行部分肾切除术或根治性肾切除术可能是一个具有挑战性的决策。
最新发现
重复和挽救性部分肾切除术虽然具有挑战性，并且可能与并发症增加有关，但为患者提供了维持良好的肾功能结果和在中期随访中具有良好的肿瘤学结果的能力。
总结
外科医生应熟悉再次肾部分切除术的手术并发症以及功能和肿瘤学结果。最近的数据和结果分析支持在同侧肾脏出现局部复发或新发病灶的患者中使用这些手术。
相似文献
1
Repeat partial nephrectomy: surgical, functional and oncological outcomes.重复部分肾切除术：手术、功能和肿瘤学结果。
Curr Opin Urol. 2011 Sep;21(5):368-75. doi: 10.1097/MOU.0b013e32834964ea.
2
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.重复孤立肾部分切除术：手术、功能和肿瘤学结果。
J Urol. 2010 May;183(5):1719-24. doi: 10.1016/j.juro.2010.01.010. Epub 2010 Mar 17.
3
Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney.重复部分肾切除术与单肾初始部分肾切除术的临床结果比较。
Int J Clin Oncol. 2020 Jun;25(6):1155-1162. doi: 10.1007/s10147-020-01633-w. Epub 2020 Feb 17.
4
Tumor enucleation for small renal masses.肿瘤剜除术治疗小肾肿瘤。
Curr Opin Urol. 2012 Sep;22(5):365-71. doi: 10.1097/MOU.0b013e3283551f84.
5
Robot-assisted laparoscopic partial nephrectomy for recurrent renal-cell carcinoma in patients previously treated with nephron-sparing surgery.机器人辅助腹腔镜肾部分切除术治疗既往接受保肾手术治疗的复发性肾细胞癌。
J Endourol. 2013 Mar;27(3):309-12. doi: 10.1089/end.2012.0184. Epub 2012 Nov 12.
6
Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes.机器人辅助肾部分切除术治疗肾部分切除术后或肾肿瘤消融后局部复发：分类、技术和临床结果。
Eur Urol. 2021 Dec;80(6):730-737. doi: 10.1016/j.eururo.2021.04.003. Epub 2021 Jun 2.
7
Management of locally recurrent kidney cancer.局部复发性肾癌的治疗管理。
Curr Urol Rep. 2010 Feb;11(1):15-21. doi: 10.1007/s11934-009-0085-9.
8
Preservation surgery in patients with localized renal cell cancer--nephron sparing surgery.局限性肾细胞癌患者的保留肾单位手术——保留肾单位手术。
Acta Chir Iugosl. 2014;61(1):45-9.
9
Repeat nephron-sparing surgery for children with bilateral Wilms tumor.对双侧 Wilms 瘤患儿行重复肾部分切除术。
J Pediatr Surg. 2014 Jan;49(1):149-53. doi: 10.1016/j.jpedsurg.2013.09.048. Epub 2013 Oct 5.
10
Oncological outcomes of partial nephrectomy for renal carcinoma greater than 4 cm.大于 4 厘米肾细胞癌行部分肾切除术的肿瘤学结果。
Curr Opin Urol. 2011 Sep;21(5):362-7. doi: 10.1097/MOU.0b013e32834963ee.
引用本文的文献
1
Repeat robotic nephron-sparing surgery for metachronous multifocal tumors in a solitary kidney: a case report.孤立肾中异时性多灶性肿瘤的重复机器人保留肾单位手术：病例报告
J Med Life. 2025 Apr;18(4):393-396. doi: 10.25122/jml-2025-0059.
2
Outcomes of Salvage Treatment After Primary Treatment for Renal Cell Cancer: A Systematic Review.肾细胞癌初次治疗后挽救性治疗的结果：一项系统评价
Diagnostics (Basel). 2025 Mar 25;15(7):838. doi: 10.3390/diagnostics15070838.
3
Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative cases.肾部分切除术后尿漏：来自遗传性、多灶性和再次手术病例队列的见解
Urol Oncol. 2025 Aug;43(8):470.e11-470.e18. doi: 10.1016/j.urolonc.2025.03.013. Epub 2025 Apr 2.
4
Effects of neoadjuvant VEGF‑TKI treatment on surgery for renal cell carcinoma: A systematic review and meta‑analysis.新辅助血管内皮生长因子酪氨酸激酶抑制剂（VEGF-TKI）治疗对肾细胞癌手术的影响：一项系统评价和荟萃分析
Oncol Lett. 2024 Feb 19;27(4):162. doi: 10.3892/ol.2024.14295. eCollection 2024 Apr.
5
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors.晚期适应症的机器人辅助部分肾切除术结果的系统评价：大肿瘤（cT2-T3）、孤立肾、完全内生性、肾门、复发性和多发性肾肿瘤。
Asian J Urol. 2023 Oct;10(4):390-406. doi: 10.1016/j.ajur.2023.06.001. Epub 2023 Aug 1.
6
Outcomes of and indications for renal transplantation in patients with von Hippel Lindau disease.von Hippel Lindau 病患者肾移植的结果和适应证。
Urol Oncol. 2023 Dec;41(12):487.e1-487.e6. doi: 10.1016/j.urolonc.2023.09.003. Epub 2023 Sep 29.
7
Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and Management.肾肿瘤保肾干预术后并发症：影像学表现与处理。
Radiographics. 2023 Jul;43(7):e220196. doi: 10.1148/rg.220196.
8
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL.了解贝佐替凡对VHL患者治疗策略的影响。
J Kidney Cancer VHL. 2022 Sep 28;9(3):41-46. doi: 10.15586/jkcvhl.v9i3.245. eCollection 2022.
9
Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localised Clear-Cell Renal Cell Carcinoma.新辅助靶向治疗在局限性透明细胞肾细胞癌患者治疗中的疗效
Adv Urol. 2021 Apr 30;2021:6674637. doi: 10.1155/2021/6674637. eCollection 2021.
10
Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma.小眼畸形相关转录因子（MITF）相关肾细胞癌的临床和分子特征。
Urology. 2021 Mar;149:89-97. doi: 10.1016/j.urology.2020.11.025. Epub 2020 Nov 24.
本文引用的文献
1
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.一项前瞻性、随机、EORTC 多组间 3 期研究比较了选择性保留肾单位手术和根治性肾切除术治疗低分期肾细胞癌的肿瘤学结局。
Eur Urol. 2011 Apr;59(4):543-52. doi: 10.1016/j.eururo.2010.12.013. Epub 2010 Dec 22.
2
Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit.在单个肾脏单位中切除至少 20 个肿瘤的部分肾切除术的可行性和结果。
J Urol. 2011 Jan;185(1):49-53. doi: 10.1016/j.juro.2010.09.032. Epub 2010 Nov 12.
3
Mini-Margin nephron sparing surgery for renal cell carcinoma 4 cm or less.适用于直径4厘米及以下肾细胞癌的微边缘保留肾单位手术。
Adv Urol. 2010;2010. doi: 10.1155/2010/145942. Epub 2010 Aug 30.
4
Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?可保留的肾实质而非肿瘤大小，应成为部分肾切除术可行性的主要决定因素吗？
Urology. 2010 Sep;76(3):608-9. doi: 10.1016/j.urology.2010.04.041.
5
Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours.与根治性肾切除术相比，部分肾切除术与意外良性肾肿瘤患者的总生存率提高相关。
Eur Urol. 2010 Aug;58(2):293-8. doi: 10.1016/j.eururo.2010.04.033. Epub 2010 May 18.
6
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.估算肾小球滤过率和白蛋白尿与普通人群全因和心血管死亡率的关系：荟萃分析协作研究。
Lancet. 2010 Jun 12;375(9731):2073-81. doi: 10.1016/S0140-6736(10)60674-5. Epub 2010 May 17.
7
Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival.对于临床 T1b 期肾肿瘤患者，选择性肾部分切除术与改善总体生存率相关。
Urology. 2010 Sep;76(3):631-7. doi: 10.1016/j.urology.2009.11.087. Epub 2010 May 10.
8
Long-term management of bilateral, multifocal, recurrent renal carcinoma.双侧、多灶、复发性肾癌的长期管理。
Nat Rev Urol. 2010 May;7(5):267-75. doi: 10.1038/nrurol.2010.44.
9
Management of locally recurrent kidney cancer.局部复发性肾癌的治疗管理。
Curr Urol Rep. 2010 Feb;11(1):15-21. doi: 10.1007/s11934-009-0085-9.
10
Predicting occult multifocality of renal cell carcinoma.预测肾细胞癌的隐匿性多灶性。
Eur Urol. 2010 Jul;58(1):118-26. doi: 10.1016/j.eururo.2010.03.011. Epub 2010 Mar 17.
Zotero 插件